Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High LDL-cholesterol Levels”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Testing effectiveness (Phase 2)Study completedNCT02597127
What this trial is testing

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Atherosclerotic Cardiovascular DiseaseFamilial HypercholesterolemiaDiabetes
The Medicines Company 501
Not applicableStudy completedNCT00574782
What this trial is testing

Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca 2,660
Post-approval studies (Phase 4)Study completedNCT00644670
What this trial is testing

The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232
Not applicableStudy completedNCT01235832
What this trial is testing

The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors

Who this might be right for
Cardiovascular DiseaseHyperlipidemia
Penn State University 54
Early research (Phase 1)Study completedNCT06229548
What this trial is testing

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053

Who this might be right for
Hyperlipemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 39
Large-scale testing (Phase 3)Study completedNCT04659863
What this trial is testing

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 13
Not applicableStudy completedNCT01200160
What this trial is testing

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Who this might be right for
Cardiovascular Diseases
Abbott 128
Post-approval studies (Phase 4)Looking for participantsNCT06501443
What this trial is testing

LATAM LOWERS LDL-C

Who this might be right for
Hypercholesterolaemia
Novartis Pharmaceuticals 520
Testing effectiveness (Phase 2)Study completedNCT01350141
What this trial is testing

A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

Who this might be right for
HypercholesterolemiaDyslipidemia
Pfizer 46
Large-scale testing (Phase 3)Study completedNCT01879319
What this trial is testing

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 164
Large-scale testing (Phase 3)Enrolling By InvitationNCT04798430
What this trial is testing

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Who this might be right for
Cardiovascular Disease With Mention of ArteriosclerosisElevated CholesterolFamilial Hypercholesterolemia
LIB Therapeutics LLC 2,000
Testing effectiveness (Phase 2)Study completedNCT01375764
What this trial is testing

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Who this might be right for
Hyperlipidemia
Amgen 160
Not applicableStudy completedNCT00114855
What this trial is testing

The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose

Who this might be right for
HyperlipidemiaGlucose Metabolism Disorders
Oslo University Hospital 40
Not applicableStudy completedNCT00240344
What this trial is testing

Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

Who this might be right for
Hypercholesterolemia
AstraZeneca 2,650
Post-approval studies (Phase 4)Study completedNCT00644709
What this trial is testing

Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 196
Testing effectiveness (Phase 2)Study completedNCT03051100
What this trial is testing

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

Who this might be right for
Hypercholesterolemia
Esperion Therapeutics, Inc. 63
Post-approval studies (Phase 4)UnknownNCT03277079
What this trial is testing

Low Dose Statins, Ezetimibe and Nutraceuticals

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Large-scale testing (Phase 3)Study completedNCT01624142
What this trial is testing

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Who this might be right for
Severe Familial Hypercholesterolemia
Amgen 300
Testing effectiveness (Phase 2)Study completedNCT03531905
What this trial is testing

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Cholesterolemia
Esperion Therapeutics, Inc. 242
Next Page